Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -35.51x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -9.57x.
INTEREST COVERAGE RATIO
-35.51x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
-39.75x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+10.67%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 448 covered companies
CURRENT VS SECTOR MEDIAN
-540.97%
vs the sector median at left
Capricor Therapeutics, Inc.
Market Cap
$442.54M
Interest Coverage Ratio
-35.51x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$441.53M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$438.49M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
Market Cap
$436.71M
Interest Coverage Ratio
-16.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$444.17M
Interest Coverage Ratio
-2.19x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$450.74M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$451.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$457.53M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
Market Cap
$422.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | $442.54M | -35.51x | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.53M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $438.49M | -17.61x | 2.56x | 1.47x | 1.63x |
| Editas Medicine, Inc. (EDIT)vs › | $436.71M | -16.10x | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $444.17M | -2.19x | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $450.74M | N/A | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $451.59M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $457.53M | 4.74x | 9.15x | 25.82x | 26.16x |
| Prothena Corporation plc (PRTA)vs › | $422.75M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $419.57M | -404.95x | N/A | N/A | N/A |
Interest Coverage
-35.5x
Debt/Equity
0.37
Current Ratio
7.35
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -9.57x |
| 2017-12-31 | -40.84x |
| 2017-09-30 | -24.50x |
| 2017-06-30 | -32.02x |
| 2017-03-31 | -33.86x |
| 2016-12-31 | -28.31x |
| 2016-09-30 | -53.06x |
| 2016-06-30 | -59.98x |
| 2016-03-31 | -63.68x |
| 2015-12-31 | -51.66x |
| 2015-09-30 | -46.22x |
| 2015-06-30 | -49.64x |
| 2015-03-31 | -55.37x |
| 2014-12-31 | -30.90x |
| 2014-09-30 | -24.71x |
| 2014-06-30 | -27.05x |
| 2014-03-31 | -46.79x |
| 2013-09-30 | -63.97x |
| 2013-06-30 | -260.02x |
| 2013-03-31 | -385.88x |
